Browsing publications by Dr Jennifer Wilkinson

Newcastle AuthorsTitleYear
Emeritus Professor Roger Francis
Professor Elaine McColl
Dr Thomas Chadwick
Christine Harle
Dr Alison Yarnall
et al.
Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D32013
Professor Stephen Proctor
Dr Jennifer Wilkinson
Gillian Watson
Dr Helen Lucraft
Dr Tryfonia Mainou-Fowler
et al.
Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study2012
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Helen Lucraft
Dr Richard McNally
Dr Tryfonia Mainou-Fowler
et al.
Comparative clinical responses of three chemotherapy schedules (VEPEMB, ABVD, CLVPP) in 175 Hodgkin Lymphoma patients over 60ys evaluated as part of the Shield (Hodgkin elderly) Study2011
Professor Anthony Moorman
Dr Lucy Chilton
Dr Jennifer Wilkinson
Hannah Ensor
Dr Nicholas Bown
et al.
A population-based cytogenetic study of adults with acute lymphoblastic leukemia2010
Professor Anthony Moorman
Dr Lucy Chilton
Dr Jennifer Wilkinson
Hannah Ensor
Natalie Bown
et al.
Age- and sex-adjusted incidence rates of adults with acute lymphoblastic leukemia (ALL) in the northern part of England Response2010
Professor Stephen Proctor
Dr Anne Lennard
Professor Graham Jackson
Dr Jennifer Wilkinson
Dr Michal Sieniawski
et al.
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control2010
Dr Michal Sieniawski
Dr Malcolm Farrow
Elaine Zhao
Dr Jennifer Wilkinson
Dr Tryfonia Mainou-Fowler
et al.
A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction Of Outcome2009
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Michal Sieniawski
Hodgkin lymphoma in the elderly: A clinical review of treatment and outcome, past, present and future2009
Dr Michal Sieniawski
Dr Jennifer Wilkinson
Professor Stephen Proctor
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone -Rituximab refractory patients2009
Dr Michal Sieniawski
Dr Jennifer Wilkinson
Dr Anne Lennard
Dr Helen Lucraft
Dr Tryfonia Mainou-Fowler
et al.
Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.2008
12